| Ms Paula Turner, | |
|
730 E 15th Street, Ada, OK 74820-3267 | |
| (580) 272-5170 | |
| Not Available |
| Full Name | Ms Paula Turner |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 730 E 15th Street, Ada, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003097908 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Paula Turner, 730 E 15th Street, Ada, OK 74820-3267 Ph: (580) 272-5170 | Ms Paula Turner, 730 E 15th Street, Ada, OK 74820-3267 Ph: (580) 272-5170 |
News Archive
The monoclonal antibody necitumumab has been approved since February 2016 for the treatment of patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) expressing non-small cell lung cancer (NSCLC) who have not received prior chemotherapy for this condition.
Mayo Clinic researchers have found a novel way to monitor real-time chemical changes in the brains of patients undergoing deep brain stimulation (DBS). The groundbreaking insight will help physicians more effectively use DBS to treat brain disorders such as Parkinson's disease, depression and Tourette syndrome.
Giving a local anaesthetic during a Caesarean section helps manage pain after the operation and can reduce consumption of painkillers, according to Cochrane Researchers. The researchers recommend local anaesthetics as part of integrated pain management strategies for Caesarean section operations, provided that consideration is given to the cost.
Laxai Pharma, Ltd. today announced that it has completed its first acquisition in the clinical research services space by purchasing all of the assets of OSR Solutions, Inc., a New Jersey based contract research organization, for $3.6 million consisting of the following: $1.5mm in cash, $0.75mm in notes, $0.60mm in assumed liabilities, and 5.6mm common shares of Laxai Pharma, Ltd. - about 10% of the issued and outstanding common shares at closing. The acquisition was financed by a combination of debt and equity.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class anti-infectives for the treatment and prevention of antibiotic-resistant infections, today reported positive results of an open-label Phase 2a trial of NVC-422 in chronically catheterized patients with significant bacteriuria, or bacteria in the urine. The study showed that NVC-422 was well tolerated and reduced or eliminated certain pathogens in the urine.
› Verified 3 days ago
Sharell Clydean Caton, LPC, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 10725 County Road 3590, Ada, OK 74820 Phone: 580-665-0211 | |
Jana Jean Webb, LPC Counselor Medicare: Medicare Enrolled Practice Location: 16050 County Road 1565, Ada, OK 74820 Phone: 405-476-1287 Fax: 580-436-9146 | |
Lonnie Roy Manuel, L.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1300 Hoppe Blvd, Suite 6, Strong Family Development, Outpatient Services-ada, Ada, OK 74820 Phone: 580-436-1222 Fax: 580-436-1333 | |
Ms. Sydney Caitlin Manning, Counselor Medicare: Not Enrolled in Medicare Practice Location: 329 W 1st St, Ada, OK 74820 Phone: 580-320-5902 | |
Jessica Lea Shores, M.S.W Counselor Medicare: Medicare Enrolled Practice Location: 111 E 12th St, Ada, OK 74820 Phone: 580-436-2690 | |
Mr. Eric Paul Hardison, Counselor Medicare: Not Enrolled in Medicare Practice Location: 17156 County Road 3543, Ada, OK 74820 Phone: 580-421-9422 |